Showing results (151-160 of 270) with videos related to

Sort By:
Pageof 27
JCO Oncology Practice|December 20, 2019
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in ItalyValentina Guarneri, Paolo Pronzato, Oscar Bertetto, et al.
BMC Cancer|October 10, 2015
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysisMichael L Marinovich, Petra Macaskill, Les Irwig, et al.
Breast (Edinburgh, Scotland)|April 18, 2026
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert ConsensusCarmine De Angelis, Dario de Biase, Lorenzo Gerratana, et al.
The Oncologist|March 20, 2023
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapyGrazia Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi, et al.
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Pathology, Research and Practice|April 7, 2022
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case seriesGiovanni Zarrilli, Valentina Angerilli, Rocco Cappellesso, et al.
Breast Cancer Research and Treatment|February 25, 2016
Whole exome sequencing of rare aggressive breast cancer histologiesMaria Vittoria Dieci, Veronika Smutná, Véronique Scott, et al.
The Oncologist|July 4, 2020
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
Pageof 27